4.7 Review

Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?

期刊

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
卷 66, 期 10, 页码 2199-2214

出版社

OXFORD UNIV PRESS
DOI: 10.1093/jac/dkr278

关键词

bacterial resistance; staphylococcal infections; healthcare-associated infections; community-associated infections

资金

  1. US NIH [5U01GM076497, 1U54GM088558, T32 AI007535-12]
  2. Pfizer
  3. Novartis
  4. i3 Innovus
  5. AIRWorldwide
  6. Avian Pandemic Flu Registry (Outcome Sciences)
  7. Roche

向作者/读者索取更多资源

Despite extensive research on the emergence of and treatments for methicillin-resistant Staphylococcus aureus (MRSA), prior studies have not rigorously evaluated the impact of methicillin resistance on the overall incidence of S. aureus infections. Yet, there are direct clinical and research implications of determining whether methicillin-susceptible S. aureus (MSSA) infection rates remain stable in the face of increasing MRSA prevalence or whether MSSA will be replaced over time. A synthesis of prior studies indicates that the emergence of healthcare-associated MRSA (HA-MRSA) and community-associated MRSA (CA-MRSA) has led to an increase in the overall incidence of S. aureus infections, with MRSA principally adding to, rather than replacing, MSSA. However, colonization with CA-MRSA may at least partially replace colonization with MSSA. So far, evidence indicates that MSSA still accounts for many infections. Therefore, eradication of MRSA alone is not sufficient to address the public health burden of S. aureus.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Antibiotic Use and Presumptive Pathogens in the Veterans Affairs Healthcare System

Christine Tedijanto, McKenna Nevers, Matthew H. Samore, Marc Lipsitch

Summary: This study analyzed patterns of antibiotic use, infectious diagnoses, and microbiological laboratory results among hospitalized patients. The majority of antibiotic use could be linked to an infectious diagnosis or microbiological specimen. However, a significant proportion of antibiotic use occurred when there was no bacterial isolate, highlighting the need for improved diagnostics to optimize antibiotic use.

CLINICAL INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study

Sarah E. Daugherty, Yinglong Guo, Kevin Heath, Micah C. Dasmarinas, Karol Giuseppe Jubilo, Jirapat Samranvedhya, Marc Lipsitch, Ken Cohen

Summary: The study evaluated the excess risk and relative hazards for developing incident clinical sequelae after the acute phase of SARS-CoV-2 infection in adults aged 18-65. The results show that individuals infected with SARS-CoV-2 may have a higher risk of developing new clinical sequelae after the acute phase compared to the control groups, with some sequelae more commonly seen in other viral illnesses.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Multidisciplinary Sciences

Indirect protection of children from SARS-CoV-2 infection through parental vaccination

Samah Hayek, Galit Shaham, Yatir Ben-Shlomo, Eldad Kepten, Noa Dagan, Daniel Nevo, Marc Lipsitch, Ben Y. Reis, Ran D. Balicer, Noam Barda

Summary: Children who are not vaccinated against SARS-CoV-2 can still be protected by vaccinated parents. A study found that having a single vaccinated parent reduced the risk of infection for unvaccinated children by 26.0% and 20.8% in two different periods, while having two vaccinated parents reduced the risk by 71.7% and 58.1%, respectively.

SCIENCE (2022)

Article Medicine, General & Internal

Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study

Ken Cohen, Sheng Ren, Kevin Heath, Micah C. Dasmarinas, Karol Giuseppe Jubilo, Yinglong Guo, Marc Lipsitch, Sarah E. Daugherty

Summary: A retrospective cohort study found that adults aged 65 and older face an increased risk of persistent and new clinical sequelae after acute infection with SARS-CoV-2, with respiratory failure, dementia, and post-viral fatigue being the most common sequelae.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Article Oncology

Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours

Ofer Margalit, Einat Shacham-Shmueli, Amit Itay, Raanan Berger, Sharon Halperin, Menucha Jurkowicz, Einav G. Levin, Liraz Olmer, Gili Regev-Yochay, Yaniv Lustig, Galia Rahav

Summary: Six months after the second dose of BNT162b2 vaccine, patients with cancer have lower seropositivity rates and RBD-IgG titres compared to healthy controls. However, the Nabs titre is similar, suggesting comparable protection among seropositive individuals. Lymphocyte count is not predictive of antibody response.

EUROPEAN JOURNAL OF CANCER (2022)

Article Medicine, General & Internal

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Ori Magen, Jacob G. Waxman, Maya Makov-Assif, Roni Vered, Dror Dicker, Miguel A. Hernan, Marc Lipsitch, Ben Y. Reis, Ran D. Balicer, Noa Dagan

Summary: The use of a fourth dose of BNT162b2 vaccine in Israel starting on January 3, 2022, has shown significant reductions in infection rate, symptomatic infection, hospitalization, and Covid-19-related deaths by February 18.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Letter Medicine, General & Internal

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron

Gili Regev-Yochay, Tal Gonen, Mayan Gilboa, Michal Mandelboim, Victoria Indenbaum, Sharon Amit, Lilac Meltzer, Keren Asraf, Carmit Cohen, Ronen Fluss, Asaf Biber, Ital Nemet, Limor Kliker, Gili Joseph, Ram Doolman, Ella Mendelson, Laurence S. Freedman, Dror Harats, Yitshak Kreiss, Yaniv Lustig

Summary: Health care workers in Israel received a fourth dose of mRNA vaccine during the prevalence of the omicron variant. The fourth dose boosted antibody levels but did not surpass the maximum observed after the third dose. The vaccine demonstrated an efficacy of 31 to 43% against symptomatic disease.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Biochemistry & Molecular Biology

Analysis of multiple bacterial species and antibiotic classes reveals large variation in the association between seasonal antibiotic use and resistance

Daphne S. Sun, Stephen M. Kissler, Sanjat Kanjilal, Scott W. Olesen, Marc Lipsitch, Yonatan H. Grad

Summary: Understanding the relationship between antibiotic use and resistance is crucial for guiding effective strategies to limit resistance spread. Research findings showed that the use-resistance relationship varied across different pathogens and antibiotics, with resistance peaking in the winter and spring. These findings challenge the simple model of antibiotic use independently selecting for resistance and highlight the importance of considering differences between pathogens and antibiotics when developing stewardship strategies.

PLOS BIOLOGY (2022)

Article Public, Environmental & Occupational Health

Prescribing for different antibiotic classes across age groups in the Kaiser Permanente Northern California population in association with influenza incidence, 2010-2018

Edward Goldstein, Bruce H. Fireman, Nicola P. Klein, Marc Lipsitch, G. Thomas Ray

Summary: The study estimated the proportion of antibiotic prescriptions associated with influenza in the population of Kaiser Permanente Northern California, finding varying proportions among different age groups. It suggests that increasing influenza vaccination coverage may help reduce unnecessary antibiotic prescribing to mitigate antimicrobial resistance.

EPIDEMIOLOGY AND INFECTION (2022)

Article Immunology

Comparative performance of between-population vaccine allocation strategies with applications for emerging pandemics

Keya Joshi, Eva Rumpler, Lee Kennedy-Shaffer, Rafia Bosan, Marc Lipsitch

Summary: Vaccine allocation decisions during emerging pandemics are challenging due to ethical, practical, and political considerations. This study provides insights into optimal vaccine allocation strategies considering various population, vaccine, pathogen, and delivery characteristics. The findings suggest that proportional allocation based on population size performs well or comparably in minimizing the cumulative number of infections, supporting the sharing of vaccines between locations during epidemics caused by emerging pathogens.

VACCINE (2023)

Article Microbiology

Humoral Immunity of Unvaccinated COVID-19 Recovered vs. Naive BNT162b2 Vaccinated Individuals: A Prospective Longitudinal Study

Gili Joseph, Carmit Cohen, Carmit Rubin, Havi Murad, Victoria Indenbaum, Keren Asraf, Yael Weiss-Ottolenghi, Gabriella Segal-Lieberman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay

Summary: In this study, we compared the immune response to SARS-CoV-2 infection and vaccination. The results showed that vaccination leads to higher initial antibody levels, but they decline more rapidly compared to the antibody response after infection. However, the antibody response after infection persists for a longer duration.

MICROORGANISMS (2023)

Article Immunology

Geographic Targeting of COVID-19 Testing to Maximize Detection in Los Angeles County

Katherine M. Jia, Rebecca Kahn, Rebecca Fisher, Sharon Balter, Marc Lipsitch

Summary: To allocate more testing resources to communities with higher test positivity, we developed and evaluated quantitative approaches for geographic targeting. The simplest model based on recent test positivity performed well in predicting communities with high positivity 2 weeks ahead.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Immunology

Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022-2023 Winter Season

Stephen Moss, Menucha Jurkowicz, Ital Nemet, Nofar Atari, Limor Kliker, Bayan Abd-Elkader, Tal Gonen, Emily Toth Martin, Yaniv Lustig, Gili Regev-Yochay, Michal Mandelboim

Summary: Concurrent administration of COVID-19 and influenza vaccines does not cause immunogenic interference and can enhance immune responses. The study findings have important implications for public health in the 2023-2024 winter season and support the co-administration of both vaccines as an effective immunization strategy.

VACCINES (2023)

Article Public, Environmental & Occupational Health

Antibiotic prescribing across age groups in the Kaiser Permanente Northern California population in association with different diagnoses, and with influenza incidence, 2010-2018

Edward Goldstein, Bruce H. Fireman, Nicola P. Klein, Marc Lipsitch, G. Thomas Ray

Summary: This study estimated the proportion of influenza-associated antibiotic prescriptions in the Kaiser Permanente Northern California population. It found that children aged 5-17 had a higher proportion of influenza-associated antibiotic prescriptions compared to children under 5. For adults aged over 20, the majority of influenza-associated antibiotic prescriptions were for respiratory diagnoses without bacterial indication.

EPIDEMIOLOGY AND INFECTION (2022)

Article Immunology

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact

Marc Lipsitch, Florian Krammer, Gili Regev-Yochay, Yaniv Lustig, Ran D. Balicer

Summary: The study evaluates the impact of breakthrough SARS-CoV-2 infections in vaccinated individuals and discusses the challenges in measuring breakthrough infections and determining the factors affecting vaccine effectiveness. The research also addresses key questions on transitioning to endemicity, tracking viral variants, identifying immune correlates of protection, and dealing with public health challenges in countering breakthrough infections amid global vaccine shortages.

NATURE REVIEWS IMMUNOLOGY (2022)

暂无数据